Cytarabine (Ara-C) in Children With Acute Promyelocytic Leukemia (APL)
NCT01191541
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
65
Enrollment
UNKNOWN
Sponsor class
Conditions
Leukemia
Interventions
DRUG:
DNR:
DRUG:
Ara-c
Sponsor
Xiaofan Zhu